Legend Capital君联资本

We’re pleased to provide our second issue of Pharmaron's BioInnovate Digest, your source for the latest advancements in biologics and cell and gene therapy. Journey alongside Pharmaron to discover how we are accelerating therapeutic development across these key modalities, helping shape the future of patient care. Stay informed by subscribing today to receive each issue. Let's drive the future of drug development together. #Pharmaron #Innovation #biologics #cgt #cellandgenetherapy #EmergingModalities #PharmonNews #BiotechNews #PharmaInnovation #FutureOfMedicine #SubscribeNow #ShareTheKnowledge Pharmaron Biologics (UK) Ltd #DrugDevelopment #PharmaInnovation #Biopharma

We are thrilled to share that Inceptio Technology has been spotlighted in ARK Invest’s Big Ideas 2025 report as the undisputed leader in real-world autonomous trucking kilometers. Inceptio-powered autonomous trucks have travelled over 35x more kilometers than the nearest peer according to the report - a testament to our focus on safety, scalability, and user-centric data-driven approach.     Why this Matters: · Data is driving autonomy: With thousands of Inceptio-powered trucks operating commercially on highways, we gather unparalleled insights to consistently refine and improve our full-stack solution. · Safety & Efficiency: Every kilometer travelled strengthens our algorithms, enabling safer commercial operations, lower costs, and higher efficiency for customers. As ARK’s analysis highlights, companies with the most real-world experience are best equipped to scale. With over 200 million kilometers achieved - and counting - we’re paving the way for greater commercial deployment of autonomous trucks. Here’s to driving innovation forward in 2025 and beyond. 🚀 Read the full report: https://lnkd.in/dvrwZ9MU #ARKInvest #BigIdeas2025 #autonomousdriving #inceptiotechnology

We are pleased to share that the National Medical Products Administration (NMPA) of China has approved the IND application for HBM9378/SKB378 (also known as WIN378), a fully human antibody targeting TSLP, for the treatment of chronic obstructive pulmonary disease (COPD). COPD is a progressive respiratory condition that poses serious health risks and a growing burden on healthcare systems. HBM9378/SKB378 is designed to inhibit TSLP-mediated signaling pathway, aiming to reduce airway inflammation and improve lung function in COPD patients. This regulatory milestone represents an important step forward in addressing the unmet needs in immunological diseases. We believe that HBM9378/SKB378, with its potential best-in-class, long-acting profile and exceptional biophysical properties, will bring meaningful benefits to patients worldwide. Learn more: https://lnkd.in/g_Ddxs7C #HarbourMice #COPD #ClinicalResearch #TSLP

𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐍𝐞𝐰𝐬! 𝐏𝐡𝐚𝐫𝐦𝐚𝐫𝐨𝐧 𝐉𝐨𝐢𝐧𝐬 𝐅𝐫𝐚𝐧𝐜𝐞 𝐁𝐢𝐨𝐭𝐞𝐜𝐡!  We are thrilled to announce our partnership with France Biotech, strengthening our commitment to innovation and collaboration in the life sciences sector. This partnership reinforces our presence in 𝐅𝐫𝐚𝐧𝐜𝐞 and across 𝐄𝐮𝐫𝐨𝐩𝐞, allowing us to engage with a vibrant network of biotech innovators, investors, and industry leaders. ➡️ 𝐀𝐛𝐨𝐮𝐭 𝐏𝐡𝐚𝐫𝐦𝐚𝐫𝐨𝐧: As a leading global life science service provider, Pharmaron offers services across the entire 𝐝𝐫𝐮𝐠 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲, 𝐩𝐫𝐞𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥, 𝐚𝐧𝐝 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐩𝐫𝐨𝐜𝐞𝐬𝐬. Our expertise spans multiple therapeutic modalities, including 𝐬𝐦𝐚𝐥𝐥 𝐦𝐨𝐥𝐞𝐜𝐮𝐥𝐞𝐬, 𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬, 𝐚𝐧𝐝 𝐂𝐆𝐓 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬. Stay tuned for more updates on our involvement with France Biotech! #Pharmaron #FranceBiotech #LifeSciences #Biotech #Innovation #DrugDiscovery

Thrilled to share that Xellar Biosystems is joining forces with Sanofi to develop advanced organ-on-chip models for vascular toxicity assessment, supported by Sanofi’s iDEA-TECH Awards. This partnership is a step forward in transforming drug testing and improving patient safety. . . #Collaboration #OrganonChip #Toxicity #DrugTesting #Biotechnology

We’re excited to announce the expansion of our off-the-shelf (OTS) antibody collection! In addition to our existing polyclonal antibodies, we now offer monoclonal antibodies—bringing you even more high-quality, rigorously validated tools for your research. Check out our new and improved Antibodies Collection Page: https://lnkd.in/gjZP_7A2 Why Choose VectorBuilder Antibodies? ✅ Extensive Selection – Target thousands of proteins across research areas like cancer, immunology, and neuroscience. ✅ Affinity-Purified & Validated – Ensuring reliable performance across multiple assays. ✅ Seamless Integration – Order vectors for gene expression, knockdown, or knockout, and pair them with the corresponding antibodies for validation.

🎉We are thrilled to announce that Hanshow has successfully completed the Climate Ambition Accelerator program, a prestigious initiative under the United Nations Global Compact (#UNGC). This accomplishment underscores our unwavering commitment to Environmental, Social, and Governance (#ESG) excellence. 💙A huge congratulations to Joy Wang and Biyan Song for your dedication and hard work throughout this transformative journey. This program has provided us with invaluable insights and tools to enhance our ESG strategies, ensuring that our operations are not only profitable but also environmentally responsible and socially conscious. 🌱 We are excited about the progress we've made and look forward to implementing these learnings to further our sustainability goals. Together, let's continue to innovate and lead in the pursuit of a greener, more sustainable world. #Hanshow #ESG #Sustainability #ClimateAction

We’re thrilled to announce that Bespin Global has officially achieved the prestigious ISO 27001 certification, the international gold standard for information security management.   This certification is a testament to our unwavering commitment to ensuring the highest level of security and data protection for our clients, partners, and stakeholders. From safeguarding sensitive information to ensuring compliance, we’re proud to offer top-tier security standards across all of our cloud services.   A huge thank you to our dedicated teams for their relentless efforts in helping us achieve this milestone. Together, we continue to build trust, reliability, and excellence in everything we do.   Stay tuned as we continue to raise the bar in cloud security! Mouteih Chaghlil · Wael Al Aaraj · Georges Debs · Ahmad Jamos · Joseph George PMP® · Luís Armada · Sunil Mohammed